NCT01418144

Brief Summary

The purpose of this study is to investigate the effectiveness of Transversus Abdominis Plane (TAP) block as a part of a multimodal postoperative pain management after laparoscopic surgery on colon.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Aug 2010

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 16, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

August 22, 2013

Status Verified

August 1, 2013

Enrollment Period

2.5 years

First QC Date

June 9, 2011

Last Update Submit

August 21, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain during cough

    VAS-pain score

    6 hours

Secondary Outcomes (3)

  • Pain during rest

    1,2,4,6,12 and 24 hours

  • Total opioid consumption

    0-24 hours

  • Postoperative nausea and vomiting

    1,2,4,6,12,18 and 24 hours

Study Arms (2)

Transversus abdominis plane (TAP) block

EXPERIMENTAL

Transversus abdominis plane (TAP) block with ropivacaine

Procedure: Transversus abdominis plane (TAP) block

Block with saline

PLACEBO COMPARATOR

Bilateral placement of 20 ml of saline 0,9% in the transversus abdominis plane

Procedure: Placebo TAP block

Interventions

Bilateral UL-guided TAP block with 20 ml of ropivacaine 0,5%

Also known as: Naropin
Transversus abdominis plane (TAP) block

Bilateral placement of 20 ml of saline 0,9% in the transversus abdominis plane

Also known as: Placebo block
Block with saline

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 - 80
  • BMI 18 - 40
  • ASA 1 - 3
  • Written consent
  • Can cooperate

You may not qualify if:

  • Mb Chron and Collitis Ulcerosa
  • Drug and alcohol abuse
  • Pregnancy
  • Consumption of opioids
  • Drug allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herlev University Hospital, Department of anaesthesia

Copenhagen, Herlev, 2730, Denmark

Location

Related Publications (1)

  • Torup H, Hansen EG, Bogeskov M, Rosenberg J, Mitchell AU, Petersen PL, Mathiesen O, Dahl JB, Moller AM. Transversus abdominis plane block after laparoscopic colonic resection in cancer patients: A randomised clinical trial. Eur J Anaesthesiol. 2016 Oct;33(10):725-30. doi: 10.1097/EJA.0000000000000510.

MeSH Terms

Interventions

Dental OcclusionRopivacaine

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2011

First Posted

August 16, 2011

Study Start

August 1, 2010

Primary Completion

February 1, 2013

Study Completion

July 1, 2013

Last Updated

August 22, 2013

Record last verified: 2013-08

Locations